open access

Vol 9, No 6 (2020)
Research paper
Published online: 2020-11-13
Get Citation

Uncontrolled type 2 diabetes mellitus in Kandahar, Afghanistan: a cross-sectional analytical study

Bilal Ahmad Rahimi, Mohibullah Mako, Najeebullah Rahimy, Abdul Wahed Wasiq
DOI: 10.5603/DK.2020.0053
·
Clinical Diabetology 2020;9(6):416-425.

open access

Vol 9, No 6 (2020)
ORIGINAL ARTICLES
Published online: 2020-11-13

Abstract

Background. Type 2 diabetes mellitus (T2DM) is one of the leading causes of mortality and morbidity worldwide. Main objective of this study was to determine the factors affecting uncontrolled T2DM.
Methods. This was a cross-sectional analytical study conducted in Kandahar, Afghanistan during July–December, 2018. Data was collected from 748 T2DM patients aged > 20 years. Data was analyzed with SPSS software using descriptive statistics, Chi square test, and binary logistic regression.
Results. Among 748 T2DM patients, 390/748 (52.1%) were females with 246/258 (95.3%) having low or middle socio-economic status. Family history of DM was present in 402/746 (53.9%) patients with 370/740 (50%) patients having uncontrolled DM. Vanaspati or animal fat was used by 728/748 (97.3%) of the patients, with 194/746 (26%) patients doing regular exercise. Oral hypoglycemic drugs were used by 666/720 (92.5%) of the patients. Comorbidities were present in 612/748 (81.8%) of the patients, with 348/748 (46.5%) having hypertension while 566/746 (75.9%) of the patients were either overweight or obese. Binary logistic regression revealed female gender (Adjusted Odds Ratio [AOR] 2.1, 95% CI 1.3–3.5), job without vigorous activity (AOR 2.2, 95% CI 1.3–3.6), and late diagnosis of DM (AOR 9.2, 95% CI 1.2–73.4) as the risk factors for uncontrolled T2DM.
Conclusion. Uncontrolled DM is prevalent in Kandahar. Proper control of the risk factors for uncontrolled DM will help in decreasing the severity and complications of DM. Diabetic services improvement, especially public awareness programs on media, is highly recommended to improve diabetic care in Kandahar.

Abstract

Background. Type 2 diabetes mellitus (T2DM) is one of the leading causes of mortality and morbidity worldwide. Main objective of this study was to determine the factors affecting uncontrolled T2DM.
Methods. This was a cross-sectional analytical study conducted in Kandahar, Afghanistan during July–December, 2018. Data was collected from 748 T2DM patients aged > 20 years. Data was analyzed with SPSS software using descriptive statistics, Chi square test, and binary logistic regression.
Results. Among 748 T2DM patients, 390/748 (52.1%) were females with 246/258 (95.3%) having low or middle socio-economic status. Family history of DM was present in 402/746 (53.9%) patients with 370/740 (50%) patients having uncontrolled DM. Vanaspati or animal fat was used by 728/748 (97.3%) of the patients, with 194/746 (26%) patients doing regular exercise. Oral hypoglycemic drugs were used by 666/720 (92.5%) of the patients. Comorbidities were present in 612/748 (81.8%) of the patients, with 348/748 (46.5%) having hypertension while 566/746 (75.9%) of the patients were either overweight or obese. Binary logistic regression revealed female gender (Adjusted Odds Ratio [AOR] 2.1, 95% CI 1.3–3.5), job without vigorous activity (AOR 2.2, 95% CI 1.3–3.6), and late diagnosis of DM (AOR 9.2, 95% CI 1.2–73.4) as the risk factors for uncontrolled T2DM.
Conclusion. Uncontrolled DM is prevalent in Kandahar. Proper control of the risk factors for uncontrolled DM will help in decreasing the severity and complications of DM. Diabetic services improvement, especially public awareness programs on media, is highly recommended to improve diabetic care in Kandahar.

Get Citation

Keywords

diabetes mellitus, DM, Kandahar, Afghanistan, risk factors, determinants

About this article
Title

Uncontrolled type 2 diabetes mellitus in Kandahar, Afghanistan: a cross-sectional analytical study

Journal

Clinical Diabetology

Issue

Vol 9, No 6 (2020)

Article type

Research paper

Pages

416-425

Published online

2020-11-13

DOI

10.5603/DK.2020.0053

Bibliographic record

Clinical Diabetology 2020;9(6):416-425.

Keywords

diabetes mellitus
DM
Kandahar
Afghanistan
risk factors
determinants

Authors

Bilal Ahmad Rahimi
Mohibullah Mako
Najeebullah Rahimy
Abdul Wahed Wasiq

References (20)
  1. World Health Organization. Global Report on Diabetes. WHO. 2016. https://www.who.int/publications-detail/global-report-on-diabetes (20.02.2019).
  2. Trapp CB, Barnard ND. Usefulness of vegetarian and vegan diets for treating type 2 diabetes. Curr Diab Rep. 2010; 10(2): 152–158.
  3. Fiagbe J, Takramah W, Axame W, et al. Risk Factors Associated with Diabetes Mellitus among Adults in the Hohoe Municipality of Ghana. Journal of Advances in Medicine and Medical Research. 2017; 23(2): 1–12.
  4. Alberti G, Zimmet P, Shaw J, et al. Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care. 2004; 27(7): 1798–1811.
  5. Koopman RJ, Mainous AG, Diaz VA, et al. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med. 2005; 3(1): 60–63.
  6. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(1): 4–14.
  7. Islam Saeed KM. Diabetes Mellitus Among Adults in Herat, Afghanistan: A Cross-Sectional Study. Cent Asian J Glob Health. 2017; 6(1): 271.
  8. Khwaja S, Islam M. Prevalence and Predictors of Diabetes Mellitus in Jalalabad City, Afghanistan-2013. Iran J DIABETES Obes. 2014; 6 (1): 1–8.
  9. Saeed K, Asghar R, Sahak M, et al. Prevalence and risk factors associated with diabetes mellitus among Kabul citizens — Afghanistan, 2012. International Journal of Diabetes in Developing Countries. 2015; 35(3): 297–303.
  10. Mir K, Saeed I. Prevalence of Diabetes and its Risk Factors in Urban Setting of Kandahar City, Afghanistan-2015. IOSR J Pharm. 2016; 6(11): 53 –60.
  11. Woldu MA, Wami CD. Factors Associated with Poor Glycemic Control among Patients with Type 2 Diabetes Mellitus in Ambo Hospital, Ambo; Ethiopia. Endocrinology & Metabolic Syndrome. 2014; 03(04).
  12. Siddiqui FJ, Avan BI, Mahmud S, et al. Uncontrolled diabetes mellitus: prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan. Diabetes Res Clin Pract. 2015; 107(1): 148–156.
  13. Almutairi MA, Said SM, Zainuddin H. Predictors of Poor Glycemic Control Among Type Two Diabetic Patients. Am J Medicine Medical Sci. 2013; 3(2): 17–21.
  14. Khattab M, Khader YS, Al-Khawaldeh A, et al. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010; 24(2): 84–89.
  15. Almutairi MA, Said SM, Zainuddin H. Predictors of Poor Glycemic Control Among Type Two Diabetic Patients. Am J Med Med Sci. 2013; 3(2): 17–21.
  16. Daly JM, Hartz AJ, Xu Y, et al. An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes. J Am Board Fam Med. 2009; 22(3): 280–290.
  17. Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario. PLoS One. 2013; 8(11): e80436.
  18. Alzaheb RA, Altemani AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes. 2018; 11: 15–21.
  19. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405–412.
  20. Nathan DM, Bayless M, Cleary P, et al. DCCT/EDIC Research Group. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013; 62(12): 3976–3986.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl